Annual report pursuant to Section 13 and 15(d)

Segment Information (Details)

v3.20.2
Segment Information (Details) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Sep. 27, 2020
Jun. 28, 2020
Mar. 29, 2020
 [1]
Dec. 29, 2019
 [1]
Sep. 29, 2019
Jun. 30, 2019
 [2]
Mar. 31, 2019
 [2]
Dec. 30, 2018
 [2]
Sep. 27, 2020
Sep. 29, 2019
Sep. 30, 2018
Segment Reporting Information [Line Items]                      
Revenues $ 8,346 [1] $ 4,893 $ 5,216 $ 5,077 $ 4,814 [2] $ 9,635 $ 4,982 $ 4,842 $ 23,531 $ 24,273 $ 22,611
EBT                 5,719 7,481 392
Total assets 35,594       32,957       35,594 32,957 32,718
Equity method investments 161       343       161 343  
Net book value of long-lived assets 3,711       3,081       3,711 3,081  
Cost of revenues                 (9,255) (8,599) (10,244)
Research and development expense                 (5,975) (5,398) (5,625)
Selling, general and administrative expense                 (2,074) (2,195) (2,986)
Other expense                 28 (414) (3,135)
Interest expense                 (602) (627) (768)
Investment and other Income, net                 66 441 539
Non-US [Member]                      
Segment Reporting Information [Line Items]                      
Net book value of long-lived assets 2,300       1,400       2,300 1,400 1,400
UNITED STATES                      
Segment Reporting Information [Line Items]                      
Revenues                 1,129 2,774 603
Net book value of long-lived assets 1,900       1,700       1,900 1,700 1,600
CHINA                      
Segment Reporting Information [Line Items]                      
Revenues                 14,001 11,610 15,149
KOREA, REPUBLIC OF                      
Segment Reporting Information [Line Items]                      
Revenues                 2,964 2,400 3,175
IRELAND                      
Segment Reporting Information [Line Items]                      
Revenues                 867 2,957 1
Other Foreign [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 4,570 4,532 3,683
Reconciling Items [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 1,974 4,891 187
EBT                 (475) 2,040 (6,002)
Total assets 28,632       27,401       28,632 27,401 26,926
Cost of revenues                 (340) (430) (486)
Research and development expense                 (1,046) (989) (1,154)
Selling, general and administrative expense                 (401) (413) (576)
Other expense                 28 (414) (3,135)
Interest expense                 (599) (619) (761)
Investment and other Income, net                 105 243 566
Reconciling Items [Member] | Licensing Agreements [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 1,841 4,723 (100)
Change of segment methodology [Member]                      
Segment Reporting Information [Line Items]                      
Research and development expense                     (474)
Impact to QTL Segment EBT due to Segment Methodology Change [Member]                      
Segment Reporting Information [Line Items]                      
EBT                   489  
Impact to QCT Segment EBT due to Segment Methodology Change [Member]                      
Segment Reporting Information [Line Items]                      
EBT                   160  
QCT [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 16,493 14,639 17,282
EBT                 2,763 2,143 2,966
Total assets 3,990       2,307       3,990 2,307 3,041
QTL [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 5,028 4,591 5,042
EBT                 3,442 2,954 3,404
Total assets 1,601       1,541       1,601 1,541 1,472
QSI [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 36 152 100
EBT                 (11) 344 24
Total assets 1,371       1,708       1,371 1,708 1,279
Equity method investments $ 110       $ 230       110 230 283
Nonreportable Segments [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 133 168 287
EBT                 $ (63) $ (61) $ (356)
[1] Revenues, operating income and net income in the fourth quarter of fiscal 2020 included $1.8 billion resulting from the settlement of our prior dispute with Huawei. Net income in the second quarter of fiscal 2020 was impacted by $265 million in non-marketable investment impairments due in part from the impact that the COVID-19 pandemic had on certain of our investees.
[2] Revenues, operating income and net income in the third quarter of fiscal 2019 included $4.7 billion resulting from the settlement with Apple and its contract manufacturers. Operating income and net income in the third quarter of fiscal 2019 were impacted by a $275 million charge related to the 2019 EC Fine. Net income in the first quarter of fiscal 2019 was impacted by an income tax benefit of $570 million due to establishing new U.S. net deferred tax assets from making certain check-the-box elections. Net income in the third quarter of fiscal 2019 was impacted by a $2.5 billion charge to income tax expense resulting from the derecognition of a deferred tax asset related to the distributed intellectual property.